Marshall Edwards, Inc says that it has added about $4 million more to its private placement, bringing its overall total in private equity placement to more than $18 million.
Marshall Edwards says it intends to use the funds generated by the private placement to fund clinical trials and pre-clinical development of new medical products.
Marshall Edwards also announced Thursday that it has entered into a $15 million standby equity distribution agreement with Cornell Capital Partners.